Jun 2026 (Q2 FY26) — Aug 5, 2026
Ardent Health Q2 FY26 — Strong Operational Execution Offsets Volume Headwinds
Read the full callArdent Health (ARDT) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Ardent Health earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1,622 | −1.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | 16.9 | −76.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$12.2 +2.09% · +$0.25
Performance −14.6% 1Y
1Y: $14.29 on 14 Oct 2025 → $12.2. High $15.21 (24 Oct 2025), low $7.83 (3 Jun 2026).
- Previous close
- $11.95
- 52-week range
- $7.83 – $15.21
- One year
- −15.86%
Overview
- Symbol
- ARDT
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Ardent Health earnings calls (ARDT)
Financials
What the filings say
Net profit, year on year: −77% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,450 | 1,606 | 1,497 | 1,645 | 1,577 | 1,605 | 1,602 | 1,622 |
| Expenses | 1,393 | 1,439 | 1,423 | 1,523 | 1,579 | 1,513 | 1,527 | 1,579 |
| Profit before tax | 57 | 167 | 74 | 122 | -2 | 92 | 75 | 43 |
| Tax rate | 19.4% | 15.8% | 20.5% | 21.6% | 154.8% | 19.6% | 21.6% | 19.7% |
| Net profit | 26 | 114 | 41 | 73 | -23 | 45 | 40 | 17 |
| EPS ($ per share) | 0.19 | — | 0.30 | 0.52 | -0.17 | — | 0.28 | 0.12 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Equity capital | — | 0 | 1 | 1 |
| Reserves | — | 155 | 366 | 502 |
| Total liabilities | — | 3,649 | 3,434 | 3,605 |
| Fixed assets | — | 811 | 862 | 936 |
| Total assets | — | 4,732 | 4,956 | 5,290 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Cash from operations | -38 | 222 | 315 | 471 |
| Cash from investing | 47 | -138 | -220 | -214 |
| Cash from financing | -270 | -102 | 25 | -103 |
| Net cash flow | -262 | -19 | 119 | 153 |
Insider filings
35 filings between Mar 11, 2026 and Sep 25, 2026.
Open market
decisions to buy or sellPurchases
$186.4K
2 purchases by 2 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 21
- Award — granted as compensation
- 12
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| DeMichiei Robert | $98.3K | — | Jun 5, 2026 |
| LUMSDAINE ALFRED | $88.1K | — | Jun 5, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | LUMSDAINE ALFRED Chief Financial Officer | Tax withheld | 3,389 | $35.7K |
| Sep 25, 2026 | Byers David Raynor SVP & Chief Accounting Officer | Tax withheld | 524 | $5.5K |
| Sep 25, 2026 | Petrovich Stephen C. EVP, GC and Secretary | Tax withheld | 788 | $8.3K |
| Jul 1, 2026 | Caspers Dave CEO and President | Award | 103,653 | $0 |
| Jun 5, 2026 | LUMSDAINE ALFRED Chief Financial Officer | Purchase | 10,000 | $88.1K |
| Jun 5, 2026 | DeMichiei Robert Director | Purchase | 11,260 | $98.3K |
| Apr 1, 2026 | Byers David Raynor SVP & Chief Accounting Officer | Award | 11,538 | $0 |
| Apr 1, 2026 | Caspers Dave Chief Operating Officer | Award | 35,673 | $0 |
| Apr 1, 2026 | BYNOE PETER C B Director | Award | 14,231 | $0 |
| Apr 1, 2026 | Campion Suzanne Director | Award | 14,231 | $0 |
| Apr 1, 2026 | GOODYEAR WILLIAM M Director | Award | 14,231 | $0 |
| Apr 1, 2026 | DeMichiei Robert Director | Award | 14,231 | $0 |
| Apr 1, 2026 | Robinson Edmondo Director | Award | 14,231 | $0 |
| Apr 1, 2026 | Webb Robert Thomas Director | Award | 14,231 | $0 |
| Apr 1, 2026 | Sen Rahul Director | Award | 14,231 | $0 |
| Apr 1, 2026 | Sotir Mark R Director | Award | 14,231 | $0 |
| Apr 1, 2026 | Havdala Ellen Director | Award | 14,231 | $0 |
| Apr 1, 2026 | Bulgarelli Peter J. Director | Award | 14,231 | $0 |
| Apr 1, 2026 | Bonick Martin President and CEO | Tax withheld | 10,952 | $95.0K |
| Apr 1, 2026 | Bonick Martin President and CEO | Award | 134,615 | $0 |
| Apr 1, 2026 | LUMSDAINE ALFRED Chief Financial Officer | Tax withheld | 4,381 | $38.0K |
| Apr 1, 2026 | LUMSDAINE ALFRED Chief Financial Officer | Award | 53,846 | $0 |
| Apr 1, 2026 | Byers David Raynor SVP & Chief Accounting Officer | Tax withheld | 924 | $8.0K |
| Apr 1, 2026 | Petrovich Stephen C. EVP, GC and Secretary | Tax withheld | 1,808 | $15.7K |
| Apr 1, 2026 | Petrovich Stephen C. EVP, GC and Secretary | Award | 24,904 | $0 |
| Apr 1, 2026 | Caspers Dave Chief Operating Officer | Tax withheld | 2,684 | $23.3K |
| Mar 31, 2026 | LUMSDAINE ALFRED Chief Financial Officer | Tax withheld | 2,510 | $21.5K |
| Mar 31, 2026 | Petrovich Stephen C. EVP, GC and Secretary | Tax withheld | 1,425 | $12.2K |
| Mar 31, 2026 | Bonick Martin President and CEO | Tax withheld | 8,026 | $68.7K |
| Mar 31, 2026 | Byers David Raynor SVP & Chief Accounting Officer | Tax withheld | 819 | $7.0K |
| Mar 11, 2026 | Chernin Ethan President of Health Services | Award | 32,408 | $0 |
| Mar 11, 2026 | LUMSDAINE ALFRED Chief Financial Officer | Award | 61,081 | $0 |
| Mar 11, 2026 | Petrovich Stephen C. EVP, GC and Secretary | Award | 34,733 | $0 |
| Mar 11, 2026 | Byers David Raynor SVP & Chief Accounting Officer | Award | 8,859 | $0 |
| Mar 11, 2026 | Bonick Martin President and CEO | Award | 195,316 | $0 |
| Sep 25, 2025 | Petrovich Stephen C. EVP, GC and Asst. Secretary | Tax withheld | 788 | $10.4K |
| Sep 25, 2025 | Byers David Raynor SVP & Chief Accounting Officer | Tax withheld | 524 | $6.9K |
| Sep 25, 2025 | LUMSDAINE ALFRED Chief Financial Officer | Tax withheld | 3,389 | $44.7K |
| Apr 2, 2025 | DeMichiei Robert Director | Award | 10,073 | $0 |
| Apr 1, 2025 | Bonick Martin President and CEO | Award | 134,927 | $0 |
| Apr 1, 2025 | LUMSDAINE ALFRED Chief Financial Officer | Award | 53,971 | $0 |
| Apr 1, 2025 | Petrovich Stephen C. EVP, GC and Asst. Secretary | Award | 22,263 | $0 |
| Apr 1, 2025 | Schultz David President Hospital Operations | Award | 26,985 | $0 |
| Apr 1, 2025 | Chernin Ethan President of Health Services | Award | 20,914 | $0 |
| Apr 1, 2025 | Byers David Raynor SVP & Chief Accounting Officer | Award | 11,565 | $0 |
| Apr 1, 2025 | Caspers Dave Chief Operating Officer | Award | 7,711 | $0 |
| Apr 1, 2025 | Caspers Dave Chief Operating Officer | Tax withheld | 2,480 | $32.2K |
| Apr 1, 2025 | Caspers Dave Chief Operating Officer | Award | 33,057 | $0 |
| Mar 31, 2025 | Schultz David President Hospital Operations | Tax withheld | 1,825 | $25.1K |
| Mar 31, 2025 | Byers David Raynor SVP & Chief Accounting Officer | Tax withheld | 676 | $9.3K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Ardent Health, Inc.
Free account. Everything above stays public.
Write why you follow Ardent Health, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading